225 related articles for article (PubMed ID: 36550572)
61. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
[TBL] [Abstract][Full Text] [Related]
62. Molecular basis of progressive familial intrahepatic cholestasis 3. A proteomics study.
Guerrero L; Carmona-Rodríguez L; Santos FM; Ciordia S; Stark L; Hierro L; Pérez-Montero P; Vicent D; Corrales FJ
Biofactors; 2024 Jan; ():. PubMed ID: 38284625
[TBL] [Abstract][Full Text] [Related]
63. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
64. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
Kong X; Kong Y; Zhang F; Wang T; Yan J
Medicine (Baltimore); 2016 Oct; 95(40):e4949. PubMed ID: 27749550
[TBL] [Abstract][Full Text] [Related]
65. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.
Harmancı Ö; Ensaroğlu F; Özçay F; Öcal S; Korkmaz M; Özdemir BH; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Nov; 13 Suppl 3():107-9. PubMed ID: 26640927
[TBL] [Abstract][Full Text] [Related]
66. Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.
Weber ND; Odriozola L; Martínez-García J; Ferrer V; Douar A; Bénichou B; González-Aseguinolaza G; Smerdou C
Nat Commun; 2019 Dec; 10(1):5694. PubMed ID: 31836711
[TBL] [Abstract][Full Text] [Related]
67. Variable Intrafamilial Expression of ABCB4 Disease.
Zampaglione L; Rougemont AL; Rubbia-Brandt L; Abramowicz M; Guipponi M; Marchionni E; Valerie M; Goossens N
ACG Case Rep J; 2023 Aug; 10(8):e01113. PubMed ID: 37575491
[TBL] [Abstract][Full Text] [Related]
68. [Clinical and genetic analysis of cases of progressive familial intrahepatic cholestasis type 3].
Shen YL; Zhang XT; Xun YH
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):307-313. PubMed ID: 37137858
[No Abstract] [Full Text] [Related]
69. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
[TBL] [Abstract][Full Text] [Related]
70. Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2.
Kondou H; Nakano S; Mizuno T; Bessho K; Hasegawa Y; Nakazawa A; Tanikawa K; Azuma Y; Okamoto T; Inui A; Imagawa K; Kasahara M; Zen Y; Suzuki M; Hayashi H
Orphanet J Rare Dis; 2024 Feb; 19(1):57. PubMed ID: 38341604
[TBL] [Abstract][Full Text] [Related]
71. Elevation of gamma-glutamyl transferase in adult: Should we think about progressive familiar intrahepatic cholestasis?
Oliveira HM; Pereira C; Santos Silva E; Pinto-Basto J; Pessegueiro Miranda H
Dig Liver Dis; 2016 Feb; 48(2):203-5. PubMed ID: 26699824
[TBL] [Abstract][Full Text] [Related]
72. The Multiple Facets of ABCB4 (MDR3) Deficiency.
Sundaram SS; Sokol RJ
Curr Treat Options Gastroenterol; 2007 Dec; 10(6):495-503. PubMed ID: 18221610
[TBL] [Abstract][Full Text] [Related]
73. ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.
Davit-Spraul A; Fabre M; Branchereau S; Baussan C; Gonzales E; Stieger B; Bernard O; Jacquemin E
Hepatology; 2010 May; 51(5):1645-55. PubMed ID: 20232290
[TBL] [Abstract][Full Text] [Related]
74. Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants.
Ben Saad A; Vauthier V; Tóth Á; Janaszkiewicz A; Durand-Schneider AM; Bruneau A; Delaunay JL; Lapalus M; Mareux E; Garcin I; Gonzales E; Housset C; Aït-Slimane T; Jacquemin E; Di Meo F; Falguières T
Liver Int; 2021 Jun; 41(6):1344-1357. PubMed ID: 33650203
[TBL] [Abstract][Full Text] [Related]
75. Current and future therapies for inherited cholestatic liver diseases.
van der Woerd WL; Houwen RH; van de Graaf SF
World J Gastroenterol; 2017 Feb; 23(5):763-775. PubMed ID: 28223721
[TBL] [Abstract][Full Text] [Related]
76. The molecular landscape of progressive familial intrahepatic cholestasis in Turkey: Defining the molecular profiles and expanding the variant spectrum.
Bakır A; Topçu V; Çavdarlı B
Ann Hum Genet; 2022 May; 86(3):119-126. PubMed ID: 34961929
[TBL] [Abstract][Full Text] [Related]
77. The wide phenotypic and genetic spectrum of ABCB4 gene deficiency: A case series.
Falcão D; Pedroto I; Moreira T
Dig Liver Dis; 2022 Feb; 54(2):221-227. PubMed ID: 34376370
[TBL] [Abstract][Full Text] [Related]
78. Heterozygous ABCB4 mutations in children with cholestatic liver disease.
Gordo-Gilart R; Hierro L; Andueza S; Muñoz-Bartolo G; López C; Díaz C; Jara P; Álvarez L
Liver Int; 2016 Feb; 36(2):258-67. PubMed ID: 26153658
[TBL] [Abstract][Full Text] [Related]
79. Comment on "Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB/c.Abcb4
Weber ND; Martínez-García J; González-Aseguinolaza G
J Hepatol; 2022 Mar; 76(3):749-751. PubMed ID: 34626730
[No Abstract] [Full Text] [Related]
80. Progressive familial intrahepatic cholestasis among the Arab population in Israel.
Naveh Y; Bassan L; Rosenthal E; Berkowitz D; Jaffe M; Mandel H; Berant M
J Pediatr Gastroenterol Nutr; 1997 May; 24(5):548-54. PubMed ID: 9161950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
